Evaluation of epidemiological factors in survival of patients with de novo myelodysplastic syndromes

Author： Elhor Gbito Kplola   Garcia-Manero Guillermo   Strom Sara  

Publisher： Springer Publishing Company

ISSN： 0957-5243

Source： Cancer Causes and Control, Vol.25, Iss.4, 2014-04, pp. : 425-435

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes

By Ma Xiaomei  

Cancer Causes and Control, Vol. 22, Iss. 4, 2011-04 ,pp. : 623-629

Springer Publishing Company

Access to resources Recommend Favorite

Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes

By Ueda Yasunori  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1450-1458

Informa Healthcare

Access to resources Recommend Favorite

Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes

By Tehranchi R.  

Medical Oncology, Vol. 23, Iss. 1, 2006-03 ,pp. : 37-49

Humana Press, Inc

Access to resources Recommend Favorite

Risk factors for myelodysplastic syndromes: a case–control study in Greece

By Dalamaga M.  

Cancer Causes and Control, Vol. 13, Iss. 7, 2002-09 ,pp. : 603-608

Springer Publishing Company

Access to resources Recommend Favorite

Biological and clinical significance of clonogenic assays in patients with myelodysplastic syndromes

By Marisavljević D.   Rolović Z.   Šefer D.   Basara N.   Ilić D.   Bošković D.   Čolović M.  

Medical Oncology, Vol. 19, Iss. 4, 2002-12 ,pp. : 249-259

Humana Press, Inc

Access to resources Recommend Favorite